Abstract:Abdominal aortic aneurysm (AAA) was previously ascribed to weaken defective medial arterial/adventitial layers, for example, smooth muscle/fibroblast cells. Therefore, besides surgical repair, medications targeting the medial layer to strengthen the aortic wall are the most feasible treatment strategy for AAA. However, so far, it is unclear whether such drugs have any beneficial effect on AAA prognosis, rate of aneurysm growth, rupture, or survival. Notably, clinical studies have shown that AAA is highly associated with endothelial dysfunction in the aged population. Additionally, animal models of endothelial dysfunction and endothelial nitric oxide synthase (eNOS) uncoupling had a very high rate of AAA formation, indicating there is crucial involvement of the endothelium and a possible pharmacological solution targeting the endothelium in AAA treatment. Endothelial cells have been found to trigger vascular wall remodeling by releasing proteases, or recruiting macrophages along with other neutrophils, into the medial layer. Moreover, inflammation and oxidative stress of the arterial wall were induced by endothelial dysfunction. Interestingly, there is a paradoxical differential correlation between diabetes and aneurysm formation in retinal capillaries and the aorta. Deciphering the significance of such a difference may explain current unsuccessful AAA medications and offer a solution to this treatment challenge. It is now believed that AAA and atherosclerosis are two separate but related diseases, based on their different clinical patterns which have further complicated the puzzle. Therefore, a thorough investigation of the interaction between endothelium and medial/adventitial layer may provide us a better understanding and new perspective on AAA formation, especially after taking into account the importance of endothelium in the development of AAA. Moreover, a novel medication strategy replacing the currently used, but suboptimal treatments for AAA, could be informed with this analysis.

Current Medical Therapeutic Prospect of Abdominal Aortic Aneurysms

Potential Medication Treatment According to Pathological Mechanisms in Abdominal Aortic Aneurysm

Status of diagnosis and therapy of abdominal aortic aneurysms

Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm

Aortic aneurysm: pathophysiology and therapeutic options

Abdominal aortic aneurysm: update on pathogenesis and medical treatments

The future for the therapeutics of abdominal aortic aneurysm: engineered nanoparticles drug delivery for abdominal aortic aneurysm

Endothelium as a Potential Target for Treatment of Abdominal Aortic Aneurysm

Therapeutic potential of natural products and underlying targets for the treatment of aortic aneurysm

Treatment of the Abdominal Aortic Aneurysms

Epigenetic modifications in abdominal aortic aneurysms: from basic to clinical

The mechanism and therapy of aortic aneurysms

Understanding the Potential Function of Perivascular Adipose Tissue in Abdominal Aortic Aneurysms: Current Research Status and Future Expectation

Diagnosis and treatment of particular types of abdominal aortic aneurysms

Advances and challenges in regenerative therapies for abdominal aortic aneurysm

Current Pharmacological Management of Aortic Aneurysm

Effect of Matrix Metalloproteinase and Its Inhibitor in the Formation of Abdominal Aortic Aneurysms

Molecular targets in aortic aneurysm for establishing novel management paradigms

Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm

Medical treatments for abdominal aortic aneurysm: an overview of clinical trials

Progress on the Role of Vascular Endothelial Cells in the Formation of Aortic Aneurysms